Award notice Supplies

2026-90 Suministro del medicamento Lisocabtágeno maraleucel (Breyanzi®) para el Hospital Clínic de Barcelona (HCB).

Notice published in Spanish. The AI analysis summarises it for you in your language.

Official notice and documents

Public buyer: Consorci Hospital Clínic de Barcelona (HCB)
No consta
Place of performance: BARCELONA
Estimated value: €2,539,930 excl. VAT
Amount awarded: €2,539,930 excl. VAT
Planned end of contract: 28 July 2027
likely re-tender around January 2027
Bids received: 1
Form: Framework agreement
Multi-year contract: the buyer places orders as needs arise.
Procedure: Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part.
Publication: 2 September 2026
Notice language: Spanish

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Suministro del medicamento Lisocabtagen maraleucel (Breyanzi®) para el Hospital Clínic de Barcelona (HCB).

Awarded to

BRISTOL-MYERS SQUIBB, S.A.U.

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33690000

Winning prices for comparable contracts

A quarter below: €202,502
Median: €425,325
A quarter above: €1,046,198

Amounts awarded (excl. VAT) over the last 3 years for 163 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

Contract	Winner	Amount
2026-95 Suministro de medicamentos exclusivos varios de Lab. VIIV Healthcare, S.L. Consorci Hospital Clínic de Barcelona (HCB) · 19 October 2026	Laboratorios VIIV Healthcare SL.	€10,683,365
2026-94 Suministro de medicamentos exclusivos diversos de Alexion Pharma Spain, S.L. Consorci Hospital Clínic de Barcelona (HCB) · 16 September 2026	ALEXION PHARMA SPAIN SLU	€20,964,872
2026-88 Suministro de medicamentos exclusivos diversos de Janssen Cilag, S.A. Consorci Hospital Clínic de Barcelona (HCB) · 4 September 2026	JANSSEN CILAG, S.A.	€35,598,220
2026-92 Suministro de medicamentos exclusivos diversos de Roche Farma, S.A. Consorci Hospital Clínic de Barcelona (HCB) · 4 September 2026	ROCHE FARMA, S.A.	€17,356,070
2026-93 Suministro de medicamentos exclusivos diversos de Glaxosmithkline, S.A. Consorci Hospital Clínic de Barcelona (HCB) · 4 September 2026	GLAXOSMITHKLINE, S.A.	€15,542,710

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 603105-2026.